ChatGPTClaudePerplexity
Clinical Protocol 2026|
Evidence-Based

Congenital agranulocytosis

Congenital agranulocytosis is a rare condition where a person is born without enough neutrophils, a type of white blood cell that helps fight infections

Dr. Dinesh Kumar

Verified by Dr. Dinesh Kumar

Verified

15+ Yrs Exp | MD, Specialist Physician

8/10Severity Score
Critical Management

Treatment Decisions Engine

Clinically-validated pathway for Congenital agranulocytosis

Critical Decision Checkpoints

Decision Trigger

IF: Severe infection

Recommendation:Hospitalization and broad-spectrum antibiotics

Decision Trigger

IF: Low neutrophil count

Recommendation:G-CSF therapy and close monitoring

Diagnosis and initial management

Ongoing management
Est: ₹5k - 15k

Options & Approaches

  • Genetic testing
  • Bone marrow biopsy

When this is chosen

"Confirmation of low neutrophil count and genetic mutation"

Educating patients on conservative options.

Long-term management

Ongoing management
Est: ₹5k - 15k

Options & Approaches

  • G-CSF therapy
  • Antibiotic prophylaxis

When this is chosen

"Ongoing monitoring of neutrophil count and infection risk"

Educating patients on conservative options.

Neutral Information Layer

Unbiased • Evidence-Based • Clinical

Health Mudraa's Treatment Engine objective is clarity. We explain treatment paths so you can have better conversations with your doctor.

Diagnostic Strategy

Clinical Decision Support System (CDSS) for Congenital agranulocytosis

Initial Presentation

Common reports

Recurring infectionsFeverFatigue

Differential Filter

Is it truly Congenital agranulocytosis?

  • Vs. Severe congenital neutropenia
  • Vs. Cyclic neutropenia
  • Vs. Autoimmune neutropenia

Confirmed Diagnosis

Protocol Start

Based on clinical exams and indicated diagnostic tests.

Clinical Rationale: This pathway prioritizes the exclusion of life-threatening differentials before proceeding to definitive diagnostics.

NICE/WHO Standards

Care Plan

Stage 0: Conservative

First-Line Home Care

Non-invasive interventions focusing on symptoms and lifestyle.

Home Remedies

Good hygiene practices

8/10

Frequent hand washing, avoiding close contact with people who are sick

Alternative Care

Lifestyle

Healthy diet and exercise

To help boost the immune system

Stage 1: Primary Allopathy

Standard Clinical Protocol

Verified medical treatments and pharmaceutical interventions.

  • Genetic testing
  • Bone marrow biopsy
Stage 2: Specialist Care

Advanced Interventions

Surgical or specialized procedures for persistent cases.

Criteria: Ongoing monitoring of neutrophil count and infection risk

  • G-CSF therapySurgical
  • Antibiotic prophylaxisSurgical

Emergency Triggers

  • Fever over 101.5°F

  • Severe sore throat

  • Difficulty breathing

Recovery Milestones

dependingVaries

Improved neutrophil count

Clinical Benchmark

Health Mudraa Bundles

Treatment Packages

Transparently priced, end-to-end packages designed by top hospitals for faster recovery.

Best for Diagnosis
4.9

Congenital agranulocytosis Diagnostic Bundle

4,9997,500

All Inclusive Price

  • Full Blood Panel
  • Specialist Consultation
  • Imaging (X-Ray/MRI) Support
Best for Recovery
4.9

Congenital agranulocytosis Recovery Package

12,49918,000

All Inclusive Price

  • 10 Physiotherapy Sessions
  • Dietary Consultation
  • 24/7 Support Assistant

Complete Guide to Congenital agranulocytosis

Everything you need to know about this condition

What is Congenital agranulocytosis?

Congenital agranulocytosis, also known as severe congenital neutropenia, is a rare genetic disorder characterized by a significant reduction in the production of neutrophils, a type of white blood cell that plays a crucial role in fighting infections. This condition is present at birth and can lead to recurring infections, which can be severe and life-threatening if left untreated. According to the World Health Organization (WHO), congenital agranulocytosis affects approximately 1 in 200,000 people worldwide.

Causes and Risk Factors

Congenital agranulocytosis is typically caused by genetic mutations that affect the production of neutrophils. These mutations can be inherited from one's parents or occur spontaneously during fetal development. Some genetic mutations associated with this condition include ELA2, HAX1, and G6PC3. Additionally, some cases of congenital agranulocytosis may be linked to other underlying medical conditions, such as bone marrow failure or autoimmune disorders. Lifestyle factors, such as exposure to certain chemicals or viruses, may also contribute to the development of this condition.

Signs and Symptoms

The signs and symptoms of congenital agranulocytosis can vary depending on the severity of the condition and the individual's overall health. Common symptoms include recurring infections, such as pneumonia, skin infections, and mouth sores. Other symptoms may include fever, fatigue, and swollen lymph nodes. In severe cases, congenital agranulocytosis can lead to life-threatening infections, such as sepsis or meningitis. Early signs of the condition may include frequent illnesses, poor wound healing, and delayed recovery from infections.

How is Congenital agranulocytosis Diagnosed?

Diagnosing congenital agranulocytosis typically involves a combination of physical exams, laboratory tests, and genetic analysis. A complete blood count (CBC) is usually the first step in diagnosing the condition, as it can reveal low neutrophil levels. Additional tests, such as bone marrow biopsies or genetic testing, may be necessary to confirm the diagnosis and identify the underlying genetic mutation. According to the National Institute of Health (NIH), genetic testing can identify the underlying genetic mutation in approximately 80% of cases.

Treatment Options

Treatment for congenital agranulocytosis typically involves a combination of medications, therapies, and lifestyle modifications. Granulocyte-colony stimulating factor (G-CSF) therapy is often used to stimulate the production of neutrophils. Antibiotic prophylaxis may be prescribed to prevent infections, and antifungal medications may be used to treat fungal infections. In some cases, bone marrow transplantation may be necessary to replace the defective bone marrow with healthy tissue. Additionally, patients with congenital agranulocytosis may need to take precautions to avoid infections, such as avoiding close contact with people who are sick and practicing good hygiene.

Home Care and Self-Management

There are several steps you can take to manage your condition and reduce the risk of infections. Practicing good hygiene, such as frequent hand washing and avoiding close contact with people who are sick, is essential. Maintaining a healthy diet and exercising regularly can also help boost your immune system. Additionally, you should avoid smoking and limit your exposure to chemicals and toxins. It is also important to keep your healthcare provider informed of any changes in your condition or any new symptoms that develop.

Prevention Strategies

While there is no guaranteed way to prevent congenital agranulocytosis, there are steps you can take to reduce your risk of developing the condition. If you have a family history of the condition, genetic testing may be recommended to identify any underlying genetic mutations. Additionally, practicing good hygiene and avoiding close contact with people who are sick can help reduce the risk of infections. According to the Centers for Disease Control and Prevention (CDC), getting vaccinated against certain infections, such as the flu and pneumococcal disease, can also help reduce the risk of complications.

When to See a Doctor

If you or your child is experiencing any of the following symptoms, seek medical attention immediately: fever over 101.5°F, severe sore throat, difficulty breathing, or signs of infection, such as redness, swelling, or pus. Additionally, if you have a family history of congenital agranulocytosis or have been diagnosed with the condition, it is essential to work closely with your healthcare provider to manage your condition and prevent complications.

Living with Congenital agranulocytosis

Living with congenital agranulocytosis requires ongoing management and monitoring to prevent infections and manage symptoms. With proper treatment and self-care, many people with the condition can lead active and fulfilling lives. It is essential to work closely with your healthcare provider to develop a personalized treatment plan and to stay informed about any new developments or advancements in the treatment of the condition. According to the Mayo Clinic, with proper management, people with congenital agranulocytosis can expect to live a normal lifespan. Additionally, there are several support resources available, including online forums and support groups, to help you cope with the emotional and practical challenges of living with the condition.

Dr. Dinesh Kumar

Written by Dr. Dinesh Kumar

MD, Specialist Physician • 15+ Years Experience

Last reviewed: May 2026

Crucial Medical Notice

This protocol is for informational purposes. If you are experiencing acute symptoms of Congenital agranulocytosis, please contact local emergency services or a qualified specialist immediately.

Need a Expert Second Opinion?

Consult with top-rated specialists who specialize in Congenital agranulocytosis within 15 minutes.

doctor
doctor
doctor

50+ Doctors Online

Clinical Governance

Reviewed by the Health Mudraa Clinical Council. Protocols are updated quarterly to align with NICE (UK) & WHO Global standards.

NICE
WHO
FDA

Expert-Led Treatments